Tomas Kuruc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tomas Kuruc has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Kisucka
Institute of Neurobiology of Biomedical Research Center Slovak Academy of Sciences Košice Slovakia
8 shared publications - Katarina Kiss Bimbova
Institute of Neurobiology of Biomedical Research Center Slovak Academy of Sciences Košice Slovakia
8 shared publications - Jan Galik
Biomedical Research Center of the Slovak Academy of Sciences Institute of Neurobiology Kosice Slovakia
7 shared publications - Martina Magurova
Institute of Neurobiology of Biomedical Research Center Slovak Academy of Sciences Košice Slovakia
6 shared publications - Nadežda Lukáčová
Institute of Neurobiology of Biomedical Research Center Slovak Academy of Sciences Košice Slovakia
6 shared publications - Maria Ileninova
Institute of Neurobiology of Biomedical Research Center Slovak Academy of Sciences Košice Slovakia
5 shared publications
Latest Publications
- 11 November 2026
- Published by Wiley in European Journal of Neuroscience
- Vol. 64 (9)
Region‐ and Time‐Dependent Gene Expression Responses to Siponimod, Atorvastatin and Methylprednisolone After Spinal Cord Injury
Traumatic spinal cord injury (SCI) triggers a secondary injury cascade in which microglia, infiltrating macrophages and astrocytes influence tissue degeneration and repair. These responses are dynamic and region‐dependent, yet the comparative effects of anti‐inflammatory therapies remain unclear. We evaluated siponimod, atorvastatin and methylprednisolone after Th9 compression injury in rats. Gene expression was assessed by quantitative RT‐PCR in rostral, lesion and caudal spinal cord segments at 2 and 6 weeks postinjury. At 2 weeks, all treatments reduced microglia/macrophage‐associated and inflammatory transcripts, particularly rostrally, as shown by reduced Iba1 and iNOS expression. Siponimod and atorvastatin also decreased IL‐1β rostrally, whereas siponimod was associated with region‐specific increases in inflammatory markers at the lesion site and caudally. Siponimod most consistently increased microglia/macrophage‐associated transcripts linked to immunoregulatory and reparative responses caudally, including IL1rn, TGF‐β, SOCS3 and IL4Rα. It also reduced selected inflammatory astrocyte‐associated markers and increased transcripts linked to repair‐related processes, while atorvastatin and methylprednisolone showed mixed effects. At 6 weeks, none of the treatments consistently suppressed pro‐inflammatory microglia/macrophage‐associated markers. Siponimod was associated with elevated transcripts linked to immunoregulatory and repair‐related processes, together with region‐dependent increases in inflammatory markers. Astrocyte‐associated reactivity markers were largely normalised, whereas remodelling‐associated transcripts were altered. Treatments induced modest changes in neuronal/axonal and myelin‐associated transcripts, predominantly rostrally, without significant functional improvement. Overall, these interventions differentially modulated microglia/macrophage‐ and astrocyte‐associated gene expression, with siponimod producing the broadest, but mixed and region‐dependent, gene‐expression pattern. These findings highlight the regional and stage‐dependent complexity of glial and inflammatory gene expression after pharmacological treatment of SCI.
- 11 November 2026
- Published by Wiley in European Journal of Neuroscience
- Vol. 64 (9)
Region‐ and Time‐Dependent Gene Expression Responses to Siponimod, Atorvastatin and Methylprednisolone After Spinal Cord Injury
Traumatic spinal cord injury (SCI) triggers a secondary injury cascade in which microglia, infiltrating macrophages and astrocytes influence tissue degeneration and repair. These responses are dynamic and region‐dependent, yet the comparative effects of anti‐inflammatory therapies remain unclear. We evaluated siponimod, atorvastatin and methylprednisolone after Th9 compression injury in rats. Gene expression was assessed by quantitative RT‐PCR in rostral, lesion and caudal spinal cord segments at 2 and 6 weeks postinjury. At 2 weeks, all treatments reduced microglia/macrophage‐associated and inflammatory transcripts, particularly rostrally, as shown by reduced Iba1 and iNOS expression. Siponimod and atorvastatin also decreased IL‐1β rostrally, whereas siponimod was associated with region‐specific increases in inflammatory markers at the lesion site and caudally. Siponimod most consistently increased microglia/macrophage‐associated transcripts linked to immunoregulatory and reparative responses caudally, including IL1rn, TGF‐β, SOCS3 and IL4Rα. It also reduced selected inflammatory astrocyte‐associated markers and increased transcripts linked to repair‐related processes, while atorvastatin and methylprednisolone showed mixed effects. At 6 weeks, none of the treatments consistently suppressed pro‐inflammatory microglia/macrophage‐associated markers. Siponimod was associated with elevated transcripts linked to immunoregulatory and repair‐related processes, together with region‐dependent increases in inflammatory markers. Astrocyte‐associated reactivity markers were largely normalised, whereas remodelling‐associated transcripts were altered. Treatments induced modest changes in neuronal/axonal and myelin‐associated transcripts, predominantly rostrally, without significant functional improvement. Overall, these interventions differentially modulated microglia/macrophage‐ and astrocyte‐associated gene expression, with siponimod producing the broadest, but mixed and region‐dependent, gene‐expression pattern. These findings highlight the regional and stage‐dependent complexity of glial and inflammatory gene expression after pharmacological treatment of SCI.
- 19 March 2026
- Published by Wiley in European Journal of Neuroscience
- Vol. 63 (6) , e70461
Postinjury Carnosine Treatment Prevents Neurotrophic Factor Decline in Denervated Muscle and Spinal Cord After Traumatic Injury
Local intraspinal or intramuscular administration of brain‐derived or glial cell line‐derived neurotrophic factors (BDNF, GDNF) is known to protect neural tissue after traumatic spinal cord injury (SCI). In this study, we investigated whether oral supplementation with antioxidant carnosine, a natural dipeptide, could stimulate endogenous production of these neuroprotective molecules within the neural and muscle microenvironment 6 weeks after SCI. We assessed the effects of 6‐week carnosine treatment in female Zucker rats, administered either before (CB‐I) or after injury (CA‐I). The impact of thoracic SCI and carnosine treatment was evaluated in in /active microenvironments of fore limb and hind limb muscles, along with their corresponding innervation regions. To better understand how carnosine treatment affects the neural microenvironment, we analysed mRNA expression levels of neurotrophic factors and their receptors. We also examined molecules that may indicate which cell types are involved in producing or responding to BDNF or GDNF in the spinal cord. Six weeks after thoracic SCI, we observed better locomotor recovery in CA‐I compared to CB‐I treated rats. In the hind limb, posttraumatic carnosine treatment prevented SCI‐induced reductions in BDNF and GDNF protein levels. Additionally, this treatment blocked the SCI‐induced reduction of GDNF protein levels and the oligodendrocyte‐specific gene Olig2 in the lumbar and cervical spinal cord segments. Interestingly, the postinjury treatment elevated the gene expression in BDNF receptor‐ and astrocyte‐specific genes in the cervical segments. The finding that carnosine may prevent BDNF and GDNF declines in denervated hind limb muscles positions this dipeptide as a promising candidate for inclusion in future combination therapies.
- 19 March 2026
- Published by Wiley in European Journal of Neuroscience
- Vol. 63 (6) , e70461
Postinjury Carnosine Treatment Prevents Neurotrophic Factor Decline in Denervated Muscle and Spinal Cord After Traumatic Injury
Local intraspinal or intramuscular administration of brain‐derived or glial cell line‐derived neurotrophic factors (BDNF, GDNF) is known to protect neural tissue after traumatic spinal cord injury (SCI). In this study, we investigated whether oral supplementation with antioxidant carnosine, a natural dipeptide, could stimulate endogenous production of these neuroprotective molecules within the neural and muscle microenvironment 6 weeks after SCI. We assessed the effects of 6‐week carnosine treatment in female Zucker rats, administered either before (CB‐I) or after injury (CA‐I). The impact of thoracic SCI and carnosine treatment was evaluated in in /active microenvironments of fore limb and hind limb muscles, along with their corresponding innervation regions. To better understand how carnosine treatment affects the neural microenvironment, we analysed mRNA expression levels of neurotrophic factors and their receptors. We also examined molecules that may indicate which cell types are involved in producing or responding to BDNF or GDNF in the spinal cord. Six weeks after thoracic SCI, we observed better locomotor recovery in CA‐I compared to CB‐I treated rats. In the hind limb, posttraumatic carnosine treatment prevented SCI‐induced reductions in BDNF and GDNF protein levels. Additionally, this treatment blocked the SCI‐induced reduction of GDNF protein levels and the oligodendrocyte‐specific gene Olig2 in the lumbar and cervical spinal cord segments. Interestingly, the postinjury treatment elevated the gene expression in BDNF receptor‐ and astrocyte‐specific genes in the cervical segments. The finding that carnosine may prevent BDNF and GDNF declines in denervated hind limb muscles positions this dipeptide as a promising candidate for inclusion in future combination therapies.
- Open Access
- 14 January 2026
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 20, 125-138
Endurance training mitigates obesity-induced hippocampal impairment by enhancing neurotrophin signalling, synaptic plasticity, and cellular responses in a female rat model
- 14 January 2026
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 20, 125-138
Open AccessEndurance training mitigates obesity-induced hippocampal impairment by enhancing neurotrophin signalling, synaptic plasticity, and cellular responses in a female rat model
- Open Access
- 25 February 2025
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 18, 389-399
Exploring synergistic effects: Atorvastatin and electrical stimulation in spinal cord injury therapy
- 25 February 2025
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 18, 389-399
Open AccessExploring synergistic effects: Atorvastatin and electrical stimulation in spinal cord injury therapy
- Open Access
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S238
PHARMACOLOGICAL EFFECT OF THREE CLINICALLY APPROVED ANTI-INFLAMMATORY DRUGS ON REACTIVE ASTROGLIOSIS IN SUBACUTE AND CHRONIC PHASE AFTER TH9 COMPRESSION
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S238
Open AccessPHARMACOLOGICAL EFFECT OF THREE CLINICALLY APPROVED ANTI-INFLAMMATORY DRUGS ON REACTIVE ASTROGLIOSIS IN SUBACUTE AND CHRONIC PHASE AFTER TH9 COMPRESSION
- Open Access
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S236
THE EFFECT OF SUBPIAL DELIVERY OF CHONDROITINASE ABC ON REGULATING PI3K/AKT SIGNALING PATHWAY AFTER SCI
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S236
Open AccessTHE EFFECT OF SUBPIAL DELIVERY OF CHONDROITINASE ABC ON REGULATING PI3K/AKT SIGNALING PATHWAY AFTER SCI
- Open Access
- 11 May 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (10) , 8616
Impact of Endurance Training on Regeneration of Axons, Glial Cells, and Inhibitory Neurons after Spinal Cord Injury: A Link between Functional Outcome and Regeneration Potential within the Lesion Site and in Adjacent Spinal Cord Tissue
Endurance training prior to spinal cord injury (SCI) has a beneficial effect on the activation of signaling pathways responsible for survival, neuroplasticity, and neuroregeneration. It is, however, unclear which training-induced cell populations are essential for the functional outcome after SCI. Adult Wistar rats were divided into four groups: control, six weeks of endurance training, Th9 compression (40 g/15 min), and pretraining + Th9 compression. The animals survived six weeks. Training alone increased the gene expression and protein level of immature CNP-ase oligodendrocytes (~16%) at Th10, and caused rearrangements in neurotrophic regulation of inhibitory GABA/glycinergic neurons at the Th10 and L2 levels, known to contain the interneurons with rhythmogenic potential. Training + SCI upregulated markers for immature and mature (CNP-ase, PLP1) oligodendrocytes by ~13% at the lesion site and caudally, and increased the number of GABA/glycinergic neurons in specific spinal cord regions. In the pretrained SCI group, the functional outcome of hindlimbs positively correlated with the protein levels of CNP-ase, PLP1, and neurofilaments (NF-l), but not with the outgrowing axons (Gap-43) at the lesion site and caudally. These results indicate that endurance training applied before SCI potentiates the repair in damaged spinal cord, and creates a suitable environment for neurological outcome.
- 11 May 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (10) , 8616
Open AccessImpact of Endurance Training on Regeneration of Axons, Glial Cells, and Inhibitory Neurons after Spinal Cord Injury: A Link between Functional Outcome and Regeneration Potential within the Lesion Site and in Adjacent Spinal Cord Tissue
Endurance training prior to spinal cord injury (SCI) has a beneficial effect on the activation of signaling pathways responsible for survival, neuroplasticity, and neuroregeneration. It is, however, unclear which training-induced cell populations are essential for the functional outcome after SCI. Adult Wistar rats were divided into four groups: control, six weeks of endurance training, Th9 compression (40 g/15 min), and pretraining + Th9 compression. The animals survived six weeks. Training alone increased the gene expression and protein level of immature CNP-ase oligodendrocytes (~16%) at Th10, and caused rearrangements in neurotrophic regulation of inhibitory GABA/glycinergic neurons at the Th10 and L2 levels, known to contain the interneurons with rhythmogenic potential. Training + SCI upregulated markers for immature and mature (CNP-ase, PLP1) oligodendrocytes by ~13% at the lesion site and caudally, and increased the number of GABA/glycinergic neurons in specific spinal cord regions. In the pretrained SCI group, the functional outcome of hindlimbs positively correlated with the protein levels of CNP-ase, PLP1, and neurofilaments (NF-l), but not with the outgrowing axons (Gap-43) at the lesion site and caudally. These results indicate that endurance training applied before SCI potentiates the repair in damaged spinal cord, and creates a suitable environment for neurological outcome.
- Open Access
- 17 December 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (24) , 13577
Glial-Neuronal Interactions in Pathogenesis and Treatment of Spinal Cord Injury
Traumatic spinal cord injury (SCI) elicits an acute inflammatory response which comprises numerous cell populations. It is driven by the immediate response of macrophages and microglia, which triggers activation of genes responsible for the dysregulated microenvironment within the lesion site and in the spinal cord parenchyma immediately adjacent to the lesion. Recently published data indicate that microglia induces astrocyte activation and determines the fate of astrocytes. Conversely, astrocytes have the potency to trigger microglial activation and control their cellular functions. Here we review current information about the release of diverse signaling molecules (pro-inflammatory vs. anti-inflammatory) in individual cell phenotypes (microglia, astrocytes, blood inflammatory cells) in acute and subacute SCI stages, and how they contribute to delayed neuronal death in the surrounding spinal cord tissue which is spared and functional but reactive. In addition, temporal correlation in progressive degeneration of neurons and astrocytes and their functional interactions after SCI are discussed. Finally, the review highlights the time-dependent transformation of reactive microglia and astrocytes into their neuroprotective phenotypes (M2a, M2c and A2) which are crucial for spontaneous post-SCI locomotor recovery. We also provide suggestions on how to modulate the inflammation and discuss key therapeutic approaches leading to better functional outcome after SCI.
- 17 December 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (24) , 13577
Open AccessGlial-Neuronal Interactions in Pathogenesis and Treatment of Spinal Cord Injury
Traumatic spinal cord injury (SCI) elicits an acute inflammatory response which comprises numerous cell populations. It is driven by the immediate response of macrophages and microglia, which triggers activation of genes responsible for the dysregulated microenvironment within the lesion site and in the spinal cord parenchyma immediately adjacent to the lesion. Recently published data indicate that microglia induces astrocyte activation and determines the fate of astrocytes. Conversely, astrocytes have the potency to trigger microglial activation and control their cellular functions. Here we review current information about the release of diverse signaling molecules (pro-inflammatory vs. anti-inflammatory) in individual cell phenotypes (microglia, astrocytes, blood inflammatory cells) in acute and subacute SCI stages, and how they contribute to delayed neuronal death in the surrounding spinal cord tissue which is spared and functional but reactive. In addition, temporal correlation in progressive degeneration of neurons and astrocytes and their functional interactions after SCI are discussed. Finally, the review highlights the time-dependent transformation of reactive microglia and astrocytes into their neuroprotective phenotypes (M2a, M2c and A2) which are crucial for spontaneous post-SCI locomotor recovery. We also provide suggestions on how to modulate the inflammation and discuss key therapeutic approaches leading to better functional outcome after SCI.
- Open Access
- 5 November 2021
- Published by MDPI AG in Preprints.org
Glial-Neuronal Interactions in Pathogenesis and Treatment of Spinal Cord Injury
Traumatic spinal cord injury (SCI) elicits an acute inflammatory response which comprises numerous cell populations. It is driven by the immediate response of macro-phages and reactive M1 microglia, which triggers activation of genes responsible for the dysregulated microenvironment within the lesion site and in the spinal cord parenchyma immediately adjacent to the lesion. Recently published data indicate that microglia induces astrocyte activation and determines the fate of astrocytes. Conversely, astrocytes have the potency to trigger microglial activation and control their cellular functions. Here we review current information about the release of diverse signaling molecules (pro-inflammatory vs anti-inflammatory) in individual cell phenotypes (microglia, astrocytes, blood inflammatory cells) in acute and subacute SCI stages, and how they contribute to delayed neuronal death in a the surrounding spinal cord tissue which is spared and functional but reactive. In addition, temporal correlation in progressive degeneration of neurons and astrocytes and their functional interactions after SCI are discussed. Finally, the review highlight the time-dependent transformation of reactive mi-croglia (M1) and astrocytes (A1) into their neuroprotective phenotypes (M2a, M2c and A2) which are crucial for spontaneous post-SCI locomotor recovery. We also provide sug-gestions on how to increase functional outcome after SCI and discuss key therapeutic approaches.
- 5 November 2021
- Published by MDPI AG in Preprints.org
Open AccessGlial-Neuronal Interactions in Pathogenesis and Treatment of Spinal Cord Injury
Traumatic spinal cord injury (SCI) elicits an acute inflammatory response which comprises numerous cell populations. It is driven by the immediate response of macro-phages and reactive M1 microglia, which triggers activation of genes responsible for the dysregulated microenvironment within the lesion site and in the spinal cord parenchyma immediately adjacent to the lesion. Recently published data indicate that microglia induces astrocyte activation and determines the fate of astrocytes. Conversely, astrocytes have the potency to trigger microglial activation and control their cellular functions. Here we review current information about the release of diverse signaling molecules (pro-inflammatory vs anti-inflammatory) in individual cell phenotypes (microglia, astrocytes, blood inflammatory cells) in acute and subacute SCI stages, and how they contribute to delayed neuronal death in a the surrounding spinal cord tissue which is spared and functional but reactive. In addition, temporal correlation in progressive degeneration of neurons and astrocytes and their functional interactions after SCI are discussed. Finally, the review highlight the time-dependent transformation of reactive mi-croglia (M1) and astrocytes (A1) into their neuroprotective phenotypes (M2a, M2c and A2) which are crucial for spontaneous post-SCI locomotor recovery. We also provide sug-gestions on how to increase functional outcome after SCI and discuss key therapeutic approaches.